Anti-cancer effect of camptothecin and chloroquine on the inhibition of lung cancer and breast cancer cell proliferation
Iraqi Journal of Cancer and Medical Genetics · 2025
DOI: 10.29409/g6ayyc28 ↗Abstract
Background:This research aimed to evaluate the toxic effects of chloroquine alone and in combination with camptothecin on two human cancer cell lines, namely, MCF-7 breast cancer cells and A549 lung cancer cells.Objective: To determine the percentage inhibition of breast and lung cancer cells after 72 h of exposure to treatments utilizing (originally against C. trachomatis), chloroquine and camptothecin alone and in combination and to calculate the respective half-maximal inhibitory concentration (IC50) values. Methods: Exposure to varying amounts of chloroquine, camptothecin, and a mixture of these drugs was performed for 72 hours. The percentages of growth inhibition and IC₅₀ were obtained to investigate the cytotoxic effects. Results: Single treatment with chloroquine strongly reduced cell viability in both models; however, it moderately inhibited (57 - 63%) MCF-7 cells and strongly inhibited (72 - 77%) A549 cells, suggesting that lung cancer cells are more sensitive to chloroquine. Dual treatment with chloroquine and camptothecin resulted in dose-related cytotoxic activity. The inhibition was 17 - 35% at lower doses, whereas a greater percentage of cell death occurred (52 - 67%) at higher doses. Analysis using the IC₅₀ further confirmed the presence of an interaction between the two drugs. Conclusion: These findings indicate that chloroquine potentiates the antitumor effects of CPT, especially in A549 cells.
EUVIMED